The Food and Drug Administration approved Kisunla on Tuesday for mild or early cases of dementia, only the second drug shown to delay cognitive decline The Food and Drug Administration approved Kisunla on Tuesday for mild or early cases of dementia, only the second drug shown to delay cognitive decline
Huge Alzheimer’s breakthrough as wonder drug that slows disease approved in USA
